REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
Clinical trial NCT02584465 · COMPLETED
Trial details
- NCT number
- NCT02584465
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-28
- Primary completion
- 2021-09-19
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.